- What a Personalised NICE-Guideline Treatment Plan Should Include for a Young Person
- A clear understanding of the young person’s needs
- Agreed goals that matter to the young person
- Evidence-based interventions matched to the individual
- Practical support across home and education
- Medication decisions and physical health monitoring
- Safety, confidentiality and communication
- Review arrangements and flexibility
- Support from Healing Young Minds LTD
What a Personalised NICE-Guideline Treatment Plan Should Include for a Young Person
When a child or young person is experiencing difficulties with attention, social communication, mood, anxiety, behaviour or emotional wellbeing, a clear treatment plan can provide direction and reassurance. A personalised plan sets out what support is recommended, why it is appropriate, how progress will be monitored and when the approach should be reviewed.
At Healing Young Minds LTD, treatment planning follows relevant NICE-guideline principles and is tailored to the young person’s needs, strengths, developmental stage and circumstances. The plan is developed collaboratively, rather than being a standard package applied to every child.
A clear understanding of the young person’s needs
A treatment plan should begin with a careful assessment. This includes understanding the presenting difficulties, their impact at home and in education, and how they have developed over time. For conditions such as ADHD, autism and mental health disorders, NICE recommends a thorough assessment that considers the wider context rather than focusing on symptoms in isolation.
The assessment may explore:
- Emotional, behavioural, social and developmental needs
- Strengths, interests, abilities and protective factors
- Family relationships and the home environment
- School or college experiences, learning needs and attendance
- Sleep, eating, physical health and sensory sensitivities
- Any coexisting conditions, such as anxiety, depression, learning difficulties or tics
- Safeguarding concerns, risk of harm or significant changes in functioning
This information supports a formulation: a clinically informed explanation of what may be contributing to the difficulties and what may help. A formulation is not simply a label. It helps ensure that treatment addresses the individual young person rather than only their diagnosis.
Agreed goals that matter to the young person
Effective treatment plans should identify specific, meaningful goals. These may relate to managing worry, improving concentration, attending school more consistently, developing emotional regulation skills, improving sleep or supporting relationships with family and peers.
Goals should be realistic, prioritised and reviewed over time. It can be helpful to distinguish between short-term aims, such as establishing a predictable bedtime routine, and longer-term aims, such as improving participation in education or increasing independence.
The young person should be involved in deciding what they want to work towards wherever possible. Parents and carers also have valuable information and may need support, but the child or young person’s views, preferences and rights should remain central. The level of involvement should reflect their age, understanding and ability to make decisions, alongside appropriate consent and safeguarding considerations.
Evidence-based interventions matched to the individual
A NICE-guideline treatment plan should explain which interventions are recommended and why. Treatment may include psychological therapy, practical strategies, support for parents or carers, adjustments in education, medication, or a combination of these.
The appropriate approach depends on the condition and the young person’s circumstances. For example, NICE recommendations for ADHD include environmental modifications and, where appropriate, medication and structured psychological support. Medication is not automatically required, and decisions should take account of the severity of symptoms, impairment, preferences and response to other support.
For autism, support is generally focused on the young person’s individual needs, communication, coexisting mental health conditions, sensory differences and the environment around them. Medication should not be used to treat the core features of autism. However, a clinician may consider treatment for a separate or coexisting condition when clinically indicated.
For anxiety, depression and other mental health conditions, the plan should identify the relevant NICE-guideline psychological or medical approaches, taking account of developmental needs and risk. Where medication is considered, the plan should explain the expected benefits, possible adverse effects, monitoring arrangements and alternatives.
Practical support across home and education
Children and young people do not experience their difficulties in one setting only. A plan should consider how support can be coordinated across home, school or college and healthcare services, with the young person’s consent where appropriate.
Depending on the individual, practical recommendations may include:
- Clear routines, visual prompts and predictable transitions
- Communication adjustments and additional processing time
- Support with organisation, planning and breaking tasks into manageable steps
- Access to a calm space or adjustments for sensory sensitivities
- Strategies to support emotional regulation and coping with change
- School-based pastoral, special educational needs or attendance support
- Parent or carer guidance to promote consistent responses at home
These recommendations should be specific enough to be useful. A plan that simply advises a child to “try harder” or “manage their emotions” is unlikely to provide meaningful support. It should explain what adults can do to make success more achievable.
Medication decisions and physical health monitoring
When medication forms part of treatment, the plan should record the reason for prescribing, the intended outcome and how the response will be assessed. Medication should be discussed openly with the young person and their parents or carers, including benefits, possible side effects and what to do if concerns arise.
For ADHD medication, NICE recommends appropriate baseline assessment and ongoing monitoring. Depending on the medicine and the individual, this may include monitoring symptoms, appetite, sleep, height, weight, blood pressure and pulse. The exact monitoring schedule and clinical checks should be determined by the prescribing clinician.
Medication should not be viewed as a stand-alone solution. It should be considered alongside environmental support, psychological strategies and treatment for coexisting difficulties. If the response is limited or adverse effects occur, the plan should specify when and how treatment will be reconsidered.
Safety, confidentiality and communication
A comprehensive plan should include a clear approach to risk. This may cover thoughts of self-harm, suicidal thinking, exploitation, aggression, neglect, abuse, substance use or severe deterioration in mental state, where relevant. It should explain who to contact, what constitutes an urgent concern and when emergency services are needed.
Confidentiality should be discussed in an age-appropriate way. Young people should understand what information may be shared, why it might be shared and the limits of confidentiality where there is a serious safeguarding concern. Parents and carers should receive appropriate information and support, while respecting the young person’s developing autonomy.
Communication between professionals is also important. With suitable consent and information-sharing arrangements, the plan may need to be shared with the GP, school or college, therapist, paediatrician or other relevant services. This helps reduce duplication and supports consistent care.
Review arrangements and flexibility
A treatment plan should never be considered permanent. It should state when progress will be reviewed and what information will be used. This may include the young person’s own views, parent or carer observations, school feedback, clinical measures, physical health checks and progress towards agreed goals.
Reviews should consider whether the treatment is helping, whether new needs have emerged and whether the plan remains suitable as the young person develops. Adjustments may be required after a change of school, family circumstances, puberty, examination pressures or the emergence of another condition.
Planning should also consider transitions, including moving between services or from child and adolescent to adult care. A gradual, clearly communicated transition can help maintain continuity and reduce anxiety.
Support from Healing Young Minds LTD
A personalised NICE-guideline treatment plan should be clinically sound, understandable and practical. It should give the young person and their family a clear explanation of the recommended next steps, while allowing treatment to adapt as needs change.
To discuss an assessment or personalised treatment plan for a child or young person, contact Healing Young Minds LTD. Our Consultant Child & Adolescent Psychiatry service can provide guidance on assessment, diagnosis and treatment for autism, ADHD and mental health conditions.

